Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study on Bioequivalence of Cabergoline Tablets in Human Body
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Summary
The purpose of this study is to evaluate the bioequivalence of the test formulation and reference formulation of cabergoline tablets in healthy Chinese subjects under fasting and postprandial conditions.
Official title: A Single-center, Randomized, Open-label, Two-formulation, Two-cycle, Two-sequence, Single-dose, Crossover Bioequivalence Study of Cabergoline Tablets Under Fasting and Postprandial Conditions in Healthy Chinese Subjects
Key Details
Gender
All
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
72
Start Date
2025-06-30
Completion Date
2026-05-06
Last Updated
2025-11-17
Healthy Volunteers
Yes
Conditions
Interventions
Cabergoline tablets test formulation
Single oral administration
Cabergoline tablets reference formulation
Single oral administration
Locations (1)
Zhejiang Xiaoshan Hospital
Hangzhou, Zhejiang, China